Posted on 04/24/2009 11:14:05 PM PDT by Cindy
SNIPPET - QUOTE:
Human Swine Influenza Investigation
April 24, 2009 22:00 EST
Human cases of swine influenza A (H1N1) virus infection have been identified in the U.S. in San Diego County and Imperial County, California as well as in San Antonio, Texas. Internationally, human cases of swine influenza A (H1N1) virus infection have been identified in Mexico.
U.S. Human Cases of Swine Flu Infection State # of laboratory confirmed cases California 6 cases Texas 2 cases International Human Cases of Swine Flu Infection Country # of laboratory confirmed cases Mexico 7 cases Cases will be updated daily at 3 p.m. EST
NOTE: Only international human cases confirmed by CDC laboratories will be reported Investigations are ongoing to determine the source of the infection and whether additional people have been infected with similar swine influenza viruses.
CDC is working very closely with state and local officials in California, Texas, as well as with health officials in Mexico, Canada and the World Health Organization.
Remember: WASH YOUR HANDS.
Today we have 2 videos on CLEAN FINGERNAILS:
http://www.youtube.com/watch?v=r8IgeZgam1s
“Keep your fingernails clean”
http://www.youtube.com/watch?v=RgOlTMd7QTw
“Nail Care : How to Clean Your Nails Effectively”
http://www.freerepublic.com/focus/f-chat/2249825/posts
#
http://www.foxnews.com/story/0,2933,519976,00.html
“Report: World Health Organization Investigating Claims of Human Error Behind Swine Flu Virus”
Tuesday, May 12, 2009
SNIPPET: “Adrian Gibbs, 75, said he planned to publish a report saying the never-before-seen strain of influenza may have evolved in eggs used to grow viruses for scientific research and vaccine development, according to Bloomberg News.
The noted virologist said his findings could help better understand the microbe’s ability to spread.”
http://www.cdc.gov/h1n1flu/update.htm#statetable
###
UPDATE - Quote - Snippet:
More images
H1N1 Flu (Swine Flu)
Site last updated May 13, 2009, 11:00 AM ET
U.S. Human Cases of H1N1 Flu Infection
(As of May 13, 2009, 11:00 AM ET)
States* Laboratory confirmed cases Deaths
45 states* 3352 cases 3 deaths
*includes the District of Columbia
This table will be updated daily Monday-Friday at around 11 AM ET.
International Human Cases of Swine Flu Infection, see World Health Organization.
View state-by-state table >>
View full-sized map >>
See Also:
FluView Surveillance Report (277 KB)
For the week ending May 2, 2009
A New Virus Emerges
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in April, 2009. The virus is infecting people and is spreading from person-to-person, and has sparked a growing outbreak of illness in the United States with an increasing number of cases being reported internationally as well.
CDC anticipates that there will be more cases, more hospitalizations and more deaths associated with this new virus in the coming days and weeks because the population has little to no immunity against it. Novel influenza A (H1N1) activity is now being detected in two of CDC’s routine influenza surveillance systems as reported in the May 8, 2009 FluView. FluView is a weekly report that tracks U.S. influenza activity through multiple systems across five categories.
The May 8 FluView found that the number of people visiting their doctors with influenza-like-illness is higher than expected in the United States for this time of year. Second, laboratory data shows that regular seasonal influenza A (H1N1), (H3N2) and influenza B viruses are still circulating in the United States, but novel influenza A (H1N1) and “unsubtypable”* viruses now account for a significant number of the viruses detected in the United States.
It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
CDC continues to take aggressive action to respond to the outbreak. CDC’s response goals are to reduce the spread and severity of illness, and to provide information to help health care providers, public health officials and the public address the challenges posed by this new public health threat.
Increased Testing
CDC has developed a PCR diagnostic test kit to detect this novel H1N1 virus and has now distributed test kits to all states in the U.S. and the District of Columbia and Puerto Rico. The test kits are being shipped internationally as well. This will allow states and other countries to test for this new virus. This increase in testing will likely result in an increase in the number of confirmed cases of illness reported. This, combined with ongoing monitoring through Flu View should provide a fuller picture of the burden of disease in the United States over time.
CDC is issuing updated interim guidance daily in response to the rapidly evolving situation.
Clinician Guidance
CDC has issued interim guidance for clinicians on identifying and caring for patients with novel H1N1, in addition to providing interim guidance on the use of antiviral drugs. Influenza antiviral drugs are prescription medicines (pills, liquid or an inhaler) with activity against influenza viruses, including novel influenza H1N1 viruses. The priority use for influenza antiviral drugs during this outbreak is to treat severe influenza illness, including people who are hospitalized or sick people who are considered at high risk of serious influenza-related complications.
Public Guidance
In addition, CDC has provided guidance for the public on what to do if they become sick with flu-like symptoms, including infection with novel H1N1. CDC also has issued instructions on taking care of a sick person at home. Novel H1N1 infection has been reported to cause a wide range of symptoms, including fever, cough, sore throat, body aches, headache, chills and fatigue. In addition, a significant number of people also have reported nausea, vomiting or diarrhea. Everyone should take everyday preventive actions to stop the spread of germs, including frequent hand washing and people who are sick should stay home and avoid contact with others in order to limit further spread of the disease.
*Unsubtypable viruses are viruses that through normal testing cannot be subtyped as regularly occurring human seasonal influenza viruses. In the context of the current outbreak, it’s likely that most of these unsubtypable viruses are novel H1N1.
#
http://www.who.int/csr/don/h1n1_20090513_0600.jpg
#
QUOTE:
http://www.who.int/csr/don/2009_05_13/en/index.html
Epidemic and Pandemic Alert and Response (EPR)
Country activities | Outbreak news | Resources | Media centre
WHO > Programmes and projects > Epidemic and Pandemic Alert and Response (EPR) > Disease Outbreak News
Main content
printable version
Influenza A(H1N1) - update 27
13 May 2009 — As of 06:00 GMT, 13 May 2009, 33 countries have officially reported 5728 cases of influenza A(H1N1) infection.
Mexico has reported 2059 laboratory confirmed human cases of infection, including 56 deaths. The United States has reported 3009 laboratory confirmed human cases, including three deaths. Canada has reported 358 laboratory confirmed human cases, including one death. Costa Rica has reported eight laboratory confirmed human cases, including one death.
Related links
Map of the spread of Infuenza A(H1N1): number of laboratory confirmed cases and deaths [jpg 577kb]
As of 06:00 GMT, 13 May 2009
Influenza A(H1N1) web site
Daily updates will be posted on this site.
The following countries have reported laboratory confirmed cases with no deaths - Argentina (1), Australia (1), Austria (1), Brazil (8), China (3, comprising 1 in China, Hong Kong Special Administrative Region, and 2 in mainland China), Colombia (6), Cuba (1), Denmark (1), El Salvador (4), Finland (2), France (13), Germany (12), Guatemala (3), Ireland (1), Israel (7), Italy (9), Japan (4), Netherlands (3), New Zealand (7), Norway (2), Panama (29), Poland (1), Portugal (1), Republic of Korea (3), Spain (98), Sweden (2), Switzerland (1), Thailand (2), and the United Kingdom (68).
WHO is not recommending travel restrictions related to the outbreak of the influenza A(H1N1) virus.
Individuals who are ill should delay travel plans and returning travelers who fall ill should seek appropriate medical care. These recommendations are prudent measures which can limit the spread of many communicable diseases, including influenza.
Further information on the situation will be available on the WHO web site on a regular basis.
http://www.cdc.gov/h1n1flu/update.htm#statetable
###
UPDATE - Quote - Snippet:
More images
H1N1 Flu (Swine Flu)
Site last updated May 14, 2009, 11:00 AM ET
U.S. Human Cases of H1N1 Flu Infection
(As of May 14, 2009, 11:00 AM ET)
States* Confirmed and Probable Cases Deaths
47 states* 4,298 cases 3 deaths
*includes the District of Columbia
This table will be updated daily Monday-Friday at around 11 AM ET.
International Human Cases of Swine Flu Infection, see World Health Organization.
View state-by-state table >>
View full-sized map >>
See Also:
FluView Surveillance Report (277 KB)
For the week ending May 2, 2009
A New Influenza Virus
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in April, 2009. The virus is infecting people and is spreading from person-to-person, sparking a growing outbreak of illness in the United States. An increasing number of cases are being reported internationally as well.
It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
It’s uncertain at this time how severe this novel H1N1 outbreak will be in terms of illness and death compared with other influenza viruses. Because this is a new virus, most people will not have immunity to it, and illness may be more severe and widespread as a result. In addition, currently there is no vaccine to protect against this novel H1N1 virus. CDC anticipates that there will be more cases, more hospitalizations and more deaths associated with this new virus in the coming days and weeks.
Novel influenza A (H1N1) activity is now being detected through CDC’s routine influenza surveillance systems and reported weekly in FluView. CDC tracks U.S. influenza activity through multiple systems across five categories. The fact that novel H1N1 activity is now detected through seasonal surveillance systems is an indication that there are higher levels of influenza-like illness in the United States than is normal for this time of year. About half of all influenza viruses being detected are novel H1N1 viruses.
Learn More >>
#
http://www.who.int/csr/don/h1n1_20090514_0800.jpg
#
QUOTE:
http://www.who.int/csr/don/2009_05_14/en/index.html
Epidemic and Pandemic Alert and Response (EPR)
Country activities | Outbreak news | Resources | Media centre
WHO > Programmes and projects > Epidemic and Pandemic Alert and Response (EPR) > Disease Outbreak News
Main content
printable version
Influenza A(H1N1) - update 28
14 May 2009 — As of 06:00 GMT, 14 May 2009, 33 countries have officially reported 6497 cases of influenza A(H1N1) infection.
Mexico has reported 2446 laboratory confirmed human cases of infection, including 60 deaths. The United States has reported 3352 laboratory confirmed human cases, including three deaths. Canada has reported 389 laboratory confirmed human cases, including one death. Costa Rica has reported eight laboratory confirmed human cases, including one death.
Related links
Map of the spread of Infuenza A(H1N1): number of laboratory confirmed cases and deaths [jpg 578kb]
As of 08:00 GMT, 14 May 2009
Influenza A(H1N1) web site
Daily updates will be posted on this site.
The following countries have reported laboratory confirmed cases with no deaths - Argentina (1), Australia (1), Austria (1), Brazil (8), China (4), Colombia (7), Cuba (1), Denmark (1), El Salvador (4), Finland (2), France (14), Germany (12), Guatemala (3), Ireland (1), Israel (7), Italy (9), Japan (4), Netherlands (3), New Zealand (7), Norway (2), Panama (29), Poland (1), Portugal (1), Republic of Korea (3), Spain (100), Sweden (2), Switzerland (1), Thailand (2), and the United Kingdom (71).
WHO is not recommending travel restrictions related to the outbreak of the influenza A(H1N1) virus.
Individuals who are ill should delay travel plans and returning travelers who fall ill should seek appropriate medical care. These recommendations are prudent measures which can limit the spread of many communicable diseases, including influenza.
Further information on the situation will be available on the WHO web site on a regular basis.
QUOTE:
http://www.who.int/csr/disease/swineflu/assess/disease_swineflu_assess_20090511/en/index.html
ssessing the severity of an influenza pandemic
11 May 2009
The major determinant of the severity of an influenza pandemic, as measured by the number of cases of severe illness and deaths it causes, is the inherent virulence of the virus. However, many other factors influence the overall severity of a pandemic’s impact.
Even a pandemic virus that initially causes mild symptoms in otherwise healthy people can be disruptive, especially under the conditions of today’s highly mobile and closely interdependent societies. Moreover, the same virus that causes mild illness in one country can result in much higher morbidity and mortality in another. In addition, the inherent virulence of the virus can change over time as the pandemic goes through subsequent waves of national and international spread.
PROPERTIES OF THE VIRUS
An influenza pandemic is caused by a virus that is either entirely new or has not circulated recently and widely in the human population. This creates an almost universal vulnerability to infection. While not all people ever become infected during a pandemic, nearly all people are susceptible to infection.
The occurrence of large numbers of people falling ill at or around the same time is one reason why pandemics are socially and economically disruptive, with a potential to temporarily overburden health services.
The contagiousness of the virus also influences the severity of a pandemic’s impact, as it can increase the number of people falling ill and needing care within a short timeframe in a given geographical area. On the positive side, not all parts of the world, or all parts of a country, are affected at the same time.
The contagiousness of the virus will influence the speed of spread, both within countries and internationally. This, too, can influence severity, as very rapid spread can undermine the capacity of governments and health services to cope.
Pandemics usually have a concentrated adverse impact in specific age groups. Concentrated illnesses and deaths in a young, economically productive age group will be more disruptive to societies and economies than when the very young or very old are most severely affected, as seen during epidemics of seasonal influenza.
POPULATION VULNERABILITY
The overall vulnerability of the population can play a major role. For example, people with underlying chronic conditions, such as cardiovascular disease, hypertension, asthma, diabetes, rheumatoid arthritis, and several others, are more likely to experience severe or lethal infections. The prevalence of these conditions, combined with other factors such as nutritional status, can influence the severity of a pandemic in a significant way.
SUBSEQUENT WAVES OF SPREAD
The overall severity of a pandemic is further influenced by the tendency of pandemics to encircle the globe in at least two, sometimes three, waves. For many reasons, the severity of subsequent waves can differ dramatically in some or even most countries.
A distinctive feature of influenza viruses is that mutations occur frequently and unpredictably in the eight gene segments, and especially in the haemagglutinin gene. The emergence of an inherently more virulent virus during the course of a pandemic can never be ruled out.
Different patterns of spread can also influence the severity of subsequent waves. For example, if schoolchildren are mainly affected in the first wave, the elderly can bear the brunt of illness during the second wave, with higher mortality seen because of the greater vulnerability of elderly people.
During the previous century, the 1918 pandemic began mild and returned, within six months, in a much more lethal form. The pandemic that began in 1957 started mild, and returned in a somewhat more severe form, though significantly less devastating than seen in 1918. The 1968 pandemic began relatively mild, with sporadic cases prior to the first wave, and remained mild in its second wave in most, but not all, countries.
CAPACITY TO RESPOND
Finally, the quality of health services influences the impact of any pandemic. The same virus that causes only mild symptoms in countries with strong health systems can be devastating in other countries where health systems are weak, supplies of medicines, including antibiotics, are limited or frequently interrupted, and hospitals are crowded, poorly equipped, and under-staffed.
ASSESSMENT OF THE CURRENT SITUATION
To date, the following observations can be made, specifically about the H1N1 virus, and more generally about the vulnerability of the world population. Observations specific to H1N1 are preliminary, based on limited data in only a few countries.
The H1N1 virus strain causing the current outbreaks is a new virus that has not been seen previously in either humans or animals. Although firm conclusions cannot be reached at present, scientists anticipate that pre-existing immunity to the virus will be low or non-existent, or largely confined to older population groups.
H1N1 appears to be more contagious than seasonal influenza. The secondary attack rate of seasonal influenza ranges from 5% to 15%. Current estimates of the secondary attack rate of H1N1 range from 22% to 33%.
With the exception of the outbreak in Mexico, which is still not fully understood, the H1N1 virus tends to cause very mild illness in otherwise healthy people. Outside Mexico, nearly all cases of illness, and all deaths, have been detected in people with underlying chronic conditions.
In the two largest and best documented outbreaks to date, in Mexico and the United States of America, a younger age group has been affected than seen during seasonal epidemics of influenza. Though cases have been confirmed in all age groups, from infants to the elderly, the youth of patients with severe or lethal infections is a striking feature of these early outbreaks.
In terms of population vulnerability, the tendency of the H1N1 virus to cause more severe and lethal infections in people with underlying conditions is of particular concern.
For several reasons, the prevalence of chronic diseases has risen dramatically since 1968, when the last pandemic of the previous century occurred. The geographical distribution of these diseases, once considered the close companions of affluent societies, has likewise shifted dramatically. Today, WHO estimates that 85% of the burden of chronic diseases is now concentrated in low- and middle-income countries. In these countries, chronic diseases show an earlier average age of onset than seen in more affluent parts of the world.
In these early days of the outbreaks, some scientists speculate that the full clinical spectrum of disease caused by H1N1 will not become apparent until the virus is more widespread. This, too, could alter the current disease picture, which is overwhelmingly mild outside Mexico.
Apart from the intrinsic mutability of influenza viruses, other factors could alter the severity of current disease patterns, though in completely unknowable ways, if the virus continues to spread.
Scientists are concerned about possible changes that could take place as the virus spreads to the southern hemisphere and encounters currently circulating human viruses as the normal influenza season in that hemisphere begins.
The fact that the H5N1 avian influenza virus is firmly established in poultry in some parts of the world is another cause for concern. No one can predict how the H5N1 virus will behave under the pressure of a pandemic. At present, H5N1 is an animal virus that does not spread easily to humans and only very rarely transmits directly from one person to another.
Note: The following post is a quote:
http://www.freerepublic.com/focus/news/2251397/posts
Report: Obama selects Frieden as CDC director
AP via Breitbart ^ | May 15, 2009 | N/a
Posted on May 15, 2009 12:54:18 AM PDT by Jet Jaguar
President Barack Obama on Friday will name Dr. Thomas Frieden as director of the U.S. Centers for Disease Control and Prevention, administration officials told The New York Times.
Frieden has served as New York City’s health commissioner for the past seven years. In that time, he spearheaded a campaign to ban smoking in restaurants and bars, boosted the number of New Yorkers getting HIV tests and helped to distribute millions of free condoms.
He will inherit a looming decision on how best to manage a swine flu outbreak, including whether or how to produce a swine flu vaccine. The virus has infected 6,673 people in 35 countries.
Health experts say the CDC needs to make immediate improvements in employee morale and organization as the Obama administration works to overhaul the national health care system.
(Excerpt) Read more at breitbart.com ...
He will inherit a looming decision on how best to manage a swine flu outbreak.....”
Well, if the solution is trying to get a condom on a hog, I might prefer just getting the flu!
A humorous self bump to look through these many interesting articles. Thanks!
Putting a condom on a hog...what a visual.
You’re welcome 21twelve.
http://www.memri.org/egypt.html
#
http://www.memri.org/bin/articles.cgi?Page=countries&Area=egypt&ID=SP234409
May 6, 2009 No. 2344
“Egyptian Singer Sha’ban Abd Al-Rahim Sings about Swine Flu, Calls for Killing Pigs”
SNIPPET: “Following are excerpts from an interview with Egyptian singer Sha’ban Abd Al-Rahim, which aired on Egyptian TV on May 3, 2009. ‘Abd Al-Rahman Al-Rahim first made headlines with his pre-9/11 hit, “I Hate Israel, I Love Amr Moussa.” He followed up with an album featuring the song “Hey People, It Was Only a Tower and I Swear by God that They [the U.S.] Are the Ones Who Pulled it Down.” [1]
To view this clip on MEMRI TV, visit http://www.memritv.org/clip/en/2101.htm “
SNIPPET: “Interviewer: “You are really brave. Are you afraid of the pigs?”
Sha’ban Abd Al-Rahim: “I was worried when I heard about it and realized what was going on.”
Interviewer: “So you were singing about it even before you were afraid?
Sha’ban Abd Al-Rahim: “I didn’t even know about this influenza until Salam Khalil called me and said: We want to record a song about influenza quickly. I said to him: Why on earth influenza? And what have pigs got to do with it? He said: The world is in uproar, America and...”
Interviewer: You don’t watch the news and all that?
Sha’ban Abd Al-Rahim: “That’s the only thing I missed.”
Interviewer: “The only thing? So you follow the news?”
Sha’ban Abd Al-Rahim: “Yes, I follow things.””
#
http://portal.salud.gob.mx/descargas/pdf/influenza/situacion_actual_epidemia_140509.pdf
“Situación actual de la epidemia”
14 de mayo de 2009
Off Topic but REAL GOOD:
Video:
http://www.youtube.com/watch?v=Er59tnrZvWg
“Low and Slow Pulled Pork Barbecue Recipe by the BBQ Pit Boys”
Video:
http://www.youtube.com/watch?v=2ZirOhkZlRQ
“BBQ Pit Boys Winter Pork Ribs & Steaks”
Note: The following text is a quote:
http://www.travel.state.gov/travel/cis_pa_tw/pa/pa_3028.html
Travel Alert
U.S. DEPARTMENT OF STATE
Bureau of Consular Affairs
This information is current as of today, Sat May 16 2009 01:52:12 GMT-0700 (PDT).
2009 H1N1 Influenza
May 15, 2009
The Department of State wishes to inform U.S. citizens traveling to and residing in Mexico that on May 15 2009, the U.S. Centers for Disease Control and Prevention (CDC) lifted its recommendation that American citizens avoid all nonessential travel to Mexico. As a result of the CDC’s decision, the State Department’s Travel Alert relating to the 2009-H1N1 influenza outbreak is no longer in effect.
The CDC continues to suggest precautions that travelers and U.S. citizens resident in Mexico (especially those at high risk for complications of influenza) should take to reduce their risk of infection while in Mexico; provides recommendations for those who must travel to an area where cases of 2009-H1N1 influenza have been reported; and recommends measures travelers should take following their return from an area that has reported cases of 2009-H1N1 influenza. Complete CDC guidelines regarding H1N1 influenza can be found at the following link: http://www.cdc.gov/travel/. Please check this site frequently for updates. Americans departing Mexico for non-U.S. destinations should be aware that some governments have imposed quarantine or other screening procedures for all travelers from Mexico. Travelers may wish to check the website of the foreign country’s Embassy in the United States or Mexico for available information on current screening or quarantine procedures for travelers from Mexico. Information about entry screening procedures in other countries can be found at http://wwwn.cdc.gov/travel/content/news-announcements/delays-H1N1-screening.aspx
The Government of Mexico restarted high school (grades 10-12) and university classes on Thursday, May 7. Federal health and education officials announced that all schools from pre-school to secondary would reopen as of Monday, 11 May. However, Chiapas, Guerrero, Hidalgo, Jalisco, Michoacán, Nayarit, San Luis Potosí, and Zacatecas states extended at least some school closures until Monday, May 18 due to increases in suspected or confirmed cases of influenza 2009-H1N1, and fatalities in Jalisco and Michoacán.
Consular services at all posts in Mexico have resumed. Information on rescheduling immigrant visa appointments is available on the web page of the U.S. Consulate in Ciudad Juarez at http://ciudadjuarez.usconsulate.gov/.
The U.S. Embassy reminds U.S. citizens in Mexico that most cases of influenza are not 2009-H1N1 influenza. Any specific questions or concerns about flu or other illnesses should be directed to a medical professional. Mexico City medical authorities are urging people to avoid hospitals and clinics unless they have a medical emergency, since hospitals can be centers of infection; instead, those with health concerns are encouraged to stay home and call their physicians to avoid potential exposure. Although the U.S. Embassy cannot give medical advice or provide medical services to the public, a list of hospitals and doctors can be found on our website at the following links: http://mexico.usembassy.gov/sacs_medical_info.html (Spanish) http://mexico.usembassy.gov/eng/eacs_medical_info.html (English).
For additional information, please consult the State Department’s website at www.travel.state.gov, the CDC website at www.cdc.gov, or the website of the World Health Organization at www.who.int. The U.S.-based call center for U.S. citizens can be reached at 1-888-407-4747 from 8:00 am – 8:00 pm Eastern Daylight Time, Monday through Friday or, if calling from outside the U.S., at (202)-501-4444. The U.S. Embassy will post additional information as it becomes available at: http://mexico.usembassy.gov. American citizens traveling or residing overseas are encouraged to register with the appropriate U.S. Embassy or Consulate on the State Department’s travel registration website at https://travelregistration.state.gov/.
For any emergencies involving U.S. citizens in Mexico, please contact the closest U.S. Embassy or Consulate. The U.S. Embassy is located in Mexico City at Paseo de la Reforma 305, Colonia Cuauhtemoc, telephone from the United States: 011-52-55-5080-2000; telephone within Mexico City: 5080-2000; telephone long distance within Mexico 01-55-5080-2000. You may also contact the Embassy by e-mail at: ACSMexicoCity@state.gov. The Embassy’s internet address is http://mexico.usembassy.gov.
Consulates:
Ciudad Juarez: Paseo de la Victoria 3650, tel. (52)(656) 227-3000. http://ciudadjuarez.usconsulate.gov.
Guadalajara: Progreso 175, telephone (52) (333) 268-2100. http://guadalajara.usconsulate.gov/.
Hermosillo: Avenida Monterrey 141, telephone (52)(662) 289-3500. http://hermosillo.usconsulate.gov.
Matamoros: Avenida Primera 2002, telephone (52)(868) 812-4402. http://matamoros.usconsulate.gov.
Merida: Calle 60 no. 338 k, telephone (52)(999) 942-5700. http://merida.usconsulate.gov.
Monterrey: Avenida Constitucion 411 Poniente, telephone (52)(818) 047-3100. http://monterrey.usconsulate.gov.
Nogales: Calle San Jose, Nogales, Sonora, telephone (52)(631) 311-8150. http://nogales.usconsulate.gov.
Nuevo Laredo: Calle Allende 3330, col. Jardin, telephone (52)(867) 714-0512. http://nuevolaredo.usconsulate.gov/.
Tijuana: Tapachula 96, telephone (52)(664) 622-7400. http://tijuana.usconsulate.gov/service.html.
Consular Agencies:
Acapulco: Hotel Continental Emporio, Costera Miguel Aleman 121 - local 14, telephone (52)(744) 484-0300 or (52)(744) 469-0556.
Cabo San Lucas: Blvd. Marina local c-4, Plaza Nautica, col. Centro, telephone (52)(624) 143-3566.
Cancún: Plaza Caracol two, second level, no. 320-323, Boulevard Kukulcan, km. 8.5, Zona Hotelera, telephone (52)(998) 883-0272.
Ciudad Acuña: Ocampo # 305, col. Centro, telephone (52)(877) 772-8661
Cozumel: Plaza Villa Mar en el Centro, Plaza Principal, (Parque Juárez between Melgar and 5th ave.) 2nd floor, locales #8 and 9, telephone (52)(987) 872-4574.
Ixtapa/Zihuatanejo: Hotel Fontan, Blvd. Ixtapa, telephone (52)(755) 553-2100.
Mazatlán: Hotel Playa Mazatlán, Playa Gaviotas #202, Zona Dorada, telephone (52)(669) 916-5889.
Oaxaca: Macedonio Alcalá no. 407, interior 20, telephone (52)(951) 514-3054 (52)(951) 516-2853.
Piedras Negras: Abasolo #211, Zona Centro, Piedras Negras, Coah., Tel. (878) 782-5586.
Playa del Carmen: “The Palapa,” Calle 1 Sur, between Avenida 15 and Avenida 20, telephone (52)(984) 873-0303.
Puerto Vallarta: Paradise Plaza, Paseo de los Cocoteros #1, Local #4, Interior #17, Nuevo Vallarta, Nayarit, telephone (52)(322) 222-0069.
Reynosa: Calle Monterrey #390, Esq. Sinaloa, Colonia Rodríguez, telephone: (52)(899) 923 - 9331
San Luis Potosí: Edificio “Las Terrazas”, Avenida Venustiano Carranza 2076-41, Col. Polanco, telephone: (52)(444) 811-7802/7803.
San Miguel de Allende: Dr. Hernandez Macias #72, telephone (52)(415) 152-2357 or (52)(415) 152-0068.
http://www.cdc.gov/h1n1flu/update.htm#statetable
###
UPDATE - Quote - Snippet:
http://www.cdc.gov/media/transcripts/2009/t090515.htm
Press Briefing Transcripts
CDC Telebriefing on Investigation of Human Cases of H1N1 Flu
May 15, 2009, 1:30 p.m. ET
Audio recording (MPEG)
Operator: Welcome, and thank you all for standing by. At this time, I would like to remind parties that your lines are on a listen-only mode until the question and answer session, at which time you can press star one to ask a question. Today’s call is being recorded. If you have any objections, you may disconnect at this time. I will now turn the meeting over to Glen Nowak. Thank you, sir, you may begin.
Dave Daigle: Actually this is Dave Daigle, Deputy Director of Media Relations. Today we’re going to have Dr. Dan Jernigan, who is the deputy director for the CDC’s influenza physician, to update us on the H1N1 virus that’s circulating. Dr. Jernigan will provide a short statement and take questions.
Dan Jernigan: Thanks a lot. The H1N1 virus continues to circulate in the United States and people continue to be ill and to be hospitalized. Today we had our fourth death reported from Maricopa county in Arizona. There are 22 U.S. states that are reporting widespread or regional influenza activity, which is something that we would not expect at this time. There are, again, more deaths and hospitalizations that we’re monitoring. There is increased amount of flu-like illness in New York City, in schools and in Houston in schools as a result of many children becoming sick with influenza-like illness that we presume will be the H1N1 virus. There are at least, in terms of our case counts, over 4,700 probable and confirmed cases in the United States.
That number is one that we’re continuing to follow. We will continue to get those numbers from the states that report to us, but the numbers are becoming less important as we move through the increasing numbers of cases. And so we are monitoring the influenza through other surveillance systems that the CDC and state health departments maintain. What we’re seeing is there is geographic variation in H1N1 flu activity, and that is the activity appears to be highest in the Pacific Northwest and in southwest and in other areas of the country. So we expect, just as with seasonal flu, that the flu will appear in different places. It will come, it will go, so we’re trying to monitor that. But overall, we’re seeing increased activity.
There are four known fatalities, like I mentioned. There are 173 hospitalizations that have been reported to CDC so far. Most of the cases that we have, again, remain among younger people in the ages of 5 to 24 years old. But unlike seasonal flu, we’re still seeing relatively few cases in older individuals, and that may be just a matter of time until the virus is capable of getting to those populations, or maybe that it is a reflection of a different that this particular virus has in the populations that are affected.
Internationally, the world health organization is reporting over 7,500 confirmed cases in 34 countries. We worked — we’re continuing to work very closely with our southern hemisphere partners to monitor influenza activity as we expect that it will increase over the next months during their flu season in the southern hemisphere. In Mexico there continues to be disease. It is just as in the United States, appearing in different places at different times. Some areas being more significantly affected than others.
The estimates of the number of confirmed and probable cases in the United States are probably not the best indicator of transmission at this point because of the effect of testing, that is early on, a lot of tests were done but now the amount of testing is more targeted. And so they likely are underestimates of the actual number of people infected. And so we do know that in some places there are reporting thousands of suspect cases, and so as we know more, especially as we know more from the field teams that are doing household surveys and so forth, we will be able to have better estimates of the numbers of cases that we estimate are actually caused by influenza, the outpatient kind of illness.
There has been some discussion about the virus mutating. We’re working very closely with W.H.O., with other countries and academics and other collaborating centers around the globe to look at these viruses, to look at the gene sequences in them. And so far, we’re not seeing significant evidence of any mutation towards more virulence in the U.S. However, we’re continuing to look at these things, trying to see whether or not there are different kinds of illness that is caused by them. But at this point, nothing that we are able to say about any change that has occurred in the virus.
In terms of CDC’s response, we have more than 100 CDC staff that are in the field. Also in terms of helping to detect the H1N1 virus around the globe, we are working with the world health organization to distribute test kits. We distributed to 95 laboratories in all 50 states in the U.S. and to 237 laboratories in 107 countries. And we hope that having those very sensitive tests out around the globe, we will be able to get a good sense early on about where the virus is occurring. At this point, we’re not seeing the seriousness of illness that was initially reported in Mexico in the United States, but this certainly does not mean that the outbreak is over. The H1N1 virus is not going away. We know that the outbreak is not localized but is spreading and appears to be expanding throughout the United States.
So, this is an ongoing public health threat and continued vigilance and action is needed. And for the upcoming fall flu season, it is critically important for everyone now to be prepared and to follow with us and if you have illness, to see your doctor. If you’re sick, stay home. Use those appropriate hygiene that we have described and follow with us on our website regarding the numbers of cases, the amount of illness and the guidance that’s being developed at CDC.gov.
Dave Daigle: Thank you, Dr. Jernigan. Operator, at this time, we will take the first question.
Operator: The first question is from Robert Lowes, MedScape Medical News. Your line is open.
Robert Lowes: Thank you, Dr. Jernigan. Now, The New York Times reported that a researcher investigating cases in Mexico found that one-third of the hospitalized patients from this flu did not have fever, which is odd in his view because that is typically a symptom of seasonal flu, and one-third of the patients he looked at didn’t have that symptom. Is that also something that you have discovered in the United States? And if so, what does that say about the virus and screening for it?
Dan Jernigan: Well, the report indicated that a number of people did not have fever. That is into the what we have seen so far in the United States. Of those that are hospitalized, all of those that we have been following have had fever except for those who might not be expected to have it, those older individuals might not have it, and some that are severely ill may not be able to mount a fever. But as a significant symptom or sign that is associated with this particular virus, we are not seeing the absence of fever as a prominent component.
Dave Daigle: Thank you, Robert. Next question, please, operator.
Operator: The next is from Rob Stein, Washington Post. Your line is open.
Rob Stein: Yeah, Hi, thank you very much for taking my question. I had a couple of questions. First was, do you have any more information about the — the latest death in Arizona? And where the other three were just to remind us. And also, I had a question about vaccine. There was an announcement today that one of the manufacturers was planning to proceed with an agument vaccine. I was wondering if that was something that the United States would be — would be able to — be interest the in using if they do ahead with that.
Dan Jernigan: Your first question regarding deaths, I would refer you to the Maricopa county and Arizona state health departments for further information on that. They have put out some press releases and have some information on their web. The other sites that deaths have occurred, there are two in Texas and one in Washington state so far. In terms of the agument vaccines, that is something in other countries they have used them for seasonal influenza. There were early on some trials of vaccines for the Avian influenza prevented sax seen but in the United States, it’s not something that has been approved for use by the FDA but we look forward to seeing how well that vaccine works and the potential for its use here.
Dave Daigle: Thank you. Next question, please, operator.
Operator: The next is from Donald McNeil, The New York Times. Your line is up.
Donald McNeil: Hi, Dr. Jernigan. There’s a growing gap between the usefulness of that 4,714 confirmed and probable cases and the actual number of cases around the country. I know the teams aren’t all in yet but do you have any sort of estimate at all about how many cases we’re talking about across the country? Is it 10,000, 20,000, 30,000? Any sense at all of what the real number is like?
Dan Jernigan: Yeah, I agree with you regarding the utility of the numeric figure for influenza. And for that reason, we don’t enumerate the numbers of individual cases each year in the United States. Somewhere between 7 percent to 10 percent of the U.S. population each year gets influenza, which is maybe 21 million to 30 million people a year. And so with the amount of activity that we’re seeing now, it’s a little hard to make an estimate about what that means in terms of the total number of people with flu out in the community. But if we had to make an estimate, I would say that the amount of activity we’re seeing with our influenza-like illness network is probably upwards of maybe 100,000, but that’s something we will have a much better estimate of once we get the information back from the field teams that are collecting that data.
Dave Daigle: Thanks, Don. Next question, please, operator?
Operator: The next is from Helen Branswell, The Canadian Press. Your line is up.
Helen Branswell: Hi, thank you very much for taking my question. I was just looking at flu watch for this week, or FluView, excuse me. And it’s really kind of interesting to see there seems to be quite a spike in activity not just for the new H1N1 but for a bunch of different types of flu. Is that an artifact of the fact that more testing is being done now than woo normally be done this time of the year, or is something weird going on?
Dan Jernigan: I can with great certainty say that that is a reflection of the amount of testing that’s going on. For those of you that follow this kind of thing, if you’re looking at the curves, you will see that there’s a nice bell shape to our season from last year — from this past season, rather. And that significant increase at the end of the season, that significant increase is a reflection of this profound amount of testing that has gone on in the last few weeks. The interesting thing, as you point out is that when we start testing everyone that looks like they have flu, we find a number of them that do have flu and what we’re find is only about half of those have the h 1 — the new h1 virus. The others have the circulating seasonal kinds of viruses. And so what that means is that there is even at this end of the usual season, the regular season, a fair amount of regular viruses that are circulating in addition to these from h1. But I think the important message is that we would be expecting to see the season to be slowing down or almost completely stopped from the kinds of surveillance systems that we normally monitor. But what we’re seeing is that there are some areas that actually have reports of the amounts of respiratory disease that are coming into their clinics that are equivalent to peak influenza season, and so that’s an indicator to us that there’s something going on with the amount of influenza disease out there. But in terms of us enumerating that, we’re not able to do that at this point.
Dave Daigle: Thank you, Helen. Next question, operator.
Operator: The next is from John Cohen, Science Magazine. Your line is open.
John Cohen: Hi. Thanks for taking my call. I wanted to clarify something Helen just asked and also ask a question about vaccines. There’s a report that several European countries have secured purchase with Glaxo of H1N1 novel, H1N1 for next year. If the U.S. makes that decision, who makes that? Is that an HHS decision? Is that a CDC decision? Who actually makes it? And is there a time line cutoff date when the decision will be made? The other question — I can wait until you answer the first one. Thanks.
Dan Jernigan: Yeah, I think vaccine decisions are made through an inner agency group within the federal government, predominantly through HHS. So that inner agency group is actively engaged right now and they are working through these issues and the key decisions are likely to be made soon regarding the U.S. plans.
Dave Daigle: The time line?
Dan Jernigan: The time line, I don’t have a time which that is but it’s as soon as possible. There are a number of factors that you know about manufacturing and so forth that require these decisions to be made very quickly.
Dave Daigle: John, what was your question about the FluView?
Dave Daigle: He had a second question.
Dan Jernigan: Yes.
Dave Daigle: Operator, I think we might have lost John.
John Cohen: I’m here.
Dan Jernigan: Excellent.
John Cohen: I’m here.
Dave Daigle: John, did you have a second question about FluView?
John Cohen: I did. You’re saying there’s increased activity from normal surveillance but it’s confusing given that there’s so much more surveillance, how do you factor out whether it’s the increased surveillance that’s leading to this abnormal activity when 50 percent of what you’re seeing is seasonal flu?
Dan Jernigan: Right. I think it’s a difference between the types of surveillance systems. So one of them is the — what we call viral logic surveillance. It’s where we actually collect the viruses and enumerate them, characterize them, et cetera. And so that’s one that is completely dependent upon people sending in specimens where they can be appropriated tested and characterized. And that’s where you see that tremendous increase at the end of this season. The other is an influenza illness network of 4,500 clinicians and other providers that tell us how many people are coming into their clinics for all causes and also tell us how many of those people are coming in with fever and influenza-like illness symptoms. And so that one is going to be less affected by media and by other factors and is not one that we stimulate through any kind of public health activity but would be in part, perhaps, reflective of some media interest. But even in the time that the interest has waned, we see that those folks are still coming in. And what we also see is that those upticks in certain regions are consistent with anecdotal reports and other reports we get of school closures and of increased illness in communities.
Dave Daigle: Thank you, John. Next question, please, operator.
Operator: The next is from David Brown, Washington Post. Your line is open.
David Brown: Yes, Hi, thanks. There’s a report that there is a — yet another new H1N1 virus that has been found in the states of Durango, Zack teakous and halisco in Mexico that is distinct from both this — this swine H1N1 and the seasonal Brisbane H1N1. Have you heard of this? And can you tell us anything about this?
Dan Jernigan: We’ve heard of some reports about that, but I have not had any direct information about the specifics of that case. So there’s ongoing dialogue between us and the folks that are in Mexico and so as we know more about that, we will be able to let people know.
Dave Daigle: Thank you, David. Next question, please, operator.
Operator: The next is from Stacey Singer, Palm Beach Post. Your line is open.
Stacey Singer: Hi. Thanks for taking my call. My question is in the serious cases where we’re seeing hospitalizations in this country and in Mexico and the deaths as well, has the site of the storm frequently play a role in the deaths? What are people dying of when they’re trying?
Dan Jernigan: The issue of side akind storm is one that clearly influenza has been associated with in the past. We have reason to believe that could be a part of the cause here. The numbers of individuals that have died that we actually have appropriate tissues and enough information to study is still pretty small. We have seen that some individuals do appear to have what looks like viral pneumonia. So that is a direct infection of the lower respiratory track by the flu virus. And so as we learn more, I think we’ll be able to say if there are unique features about the H1N1, but what we are seeing so far are the kinds of outcomes that have been previously described for influenza, but that’s something that we are very interested in and we want to learn more about.
Dave Daigle: Thank you, Stacey. Next question, please, operator.
Operator: The next is from Michelle Merrill, Hospital Employee Health. Your line is open.
Michelle Merrill: Thank you very much. I had a couple of questions. One is, do you have any idea as to how many health care workers have been infected either in the community which could pose a threat to patients in the hospital, or due to occupational exposure? And I also have a second question about your respiratory protection guidance. While that guidance has remained the same, state and local health departments around the country have differing guidance. And I’m just wondering what you think about that situation in which, you know, does that create a confusion because depending on where you live, you have different guidance about the level of respiratory protection.
Dan Jernigan: Right. I think there are a number of issues that have to be taken into account. And you’re very aware of all of them regarding protection of the workers and the ability to — to do your work given all of the protective equipment and other requirements for worker protection. At this point there have been no changes to the guidance that’s on our website. The discussions that we’re having are with NIOSH and OSHA and with others to try to identify what is the most appropriately based science guidance to offer protection in this setting.
In terms of the numbers, your question was also about the variation in guidance. When the guidances are written, in general, of course, they are all interim guidance at this point but those guidances are intended to have or offer some flex ability so that some localities based on the context can make some decisions. And so for various guidance on our web, we allow for there to be some flexibility so that states can take into account the unique activities and the unique amount of disease in those activities — in those jurisdictions and come up with the appropriate guidance. In terms of the numbers of confirmed or probable health care personnel, there are 56 confirmed or probable that we know of in 20 states. And that represents about 1.4 percent of all currently reported cases. In terms of where they’re their exposures occurred and whether or not they traveled to someplace or had exposures elsewhere and brought it into the health care setting, those are things that you our investigative teams are now working through. Because we think that’s very important information that we want to help to inform decision-making but the numbers of case that’s we have that we can ask those questions of may be too small for us to get some of the important questions answered at this time.
Dave Daigle: Thank you, Michelle. Next question, please, operator.
Operator: The next is from Kate Trainor, aghp. Your line is open.
Kate Trainor: Hi. Thank you for taking my question. I know the CDC has said you’re going to be looking very closely at the southern hemisphere for what develops down there. So I was wondering if you can tell us what specific signs you might be looking for that SEVERE disease might or might not be coming this way in the fall. And sort of on the other side of that, how do you weigh that information against the fact that the harder you look, the more stuff you’re going to find, kind of similar to what’s going on here as far as finding both the seasonal and new H1N1 flu in the northern hemisphere?
Dan Jernigan: Over the last few years, the CDC and other public health agencies have been working with folks notice southern hemisphere and in tropical areas to try to characterize with the baseline what the amount of influenza is through their seasons. For many countries in the southern hemisphere, their seasons are just now starting and will peak in the next month to two. So we want to be able to work there to identify a couple of things in particular. We want to look at severity and we want to look at the spread of infection. So there are different ways to do that. We work with the laboratories down there to characterize the viruses that are circulating. That will tell us if virus that’s we have chosen for a vaccine are still good or the right ones that are likely to come back. It will also tell us if there’s changes in the virus and also if there’s development of antiviral resistance. The next thing we would want to look at is people who are admitted for SEVERE acute respiratory illness, so there are protocols and process that’s have been worked out over the last few years that will be implemented through our partners in this regions to try to characterize that. And then finally there are estimates of the amount of influenza-like illness in the community, that we welcome working with them as well.
Dave Daigle: Thank you, Kate. Next question, please, operator.
Operator: The next is from Kafi Drexel, New York 1. Your line is open.
Kafi Drexel: Hi, how are you? Earlier today in New York City’s press conference regarding the latest cluster of H1N1 at an intermediate school here, the question was posed kind of by, why has this been happening in schools? And our outgoing health commissioner himself commented that it’s a little surprising to them because they usually don’t see this in a regular flu season where there are situations where 20 or 30 kids at a time come in with high fever on a single day. Also, it doesn’t seem like this is impacting as many older adults as usual at this point. So do you have any further insight as to why some of these clusters may be happening more in school environments? Are you looking at whether or not H1N1 is acting differently in younger people? And then also, regarding the vaccine, if you could talk a little bit more specifically on where the CDC is as far as what’s happening with that and what the thinking is as far as going ahead and developing that for fall. Looking ahead.
Dan Jernigan: Yes. I think you’re pointing out an important feature of influenza, and that is that younger people are often more affected. If we look at who gets influenza each year, the predominance, if you want to call it reservoir of influenza is in the school-aged children’ so, therefore, schools are where a younger place can congregate and share their influenza viruses amongst themselves and that often then allows for other folks to become infected as well. For this particular H1N1, it’s following along seasonal flu in that sense. But when we look at the blood of people who have — that we have collected over the past few years, we’re able to see that the older you are, the more likely you might have some evidence that you could respond somewhat to the H1N1 novel virus that’s circulating. And so what that suggests to us is that not only are skids as usual affected more, there is a chance that they may be completely naive or immune, not have any immunity to the virus. So that suggests that we want to do something to make sure that we protect them. And so while in the usual season, we may not close schools. Now it may make sense to do that. My understanding is in New York City these school closures have occurred because of the staffing issues and the number of peoples affected, and I believe that was their decision. In terms of the vaccine, as you know, there’s many steps involved with producing a flu sax seen. Vaccine. And we’re working with under HHS agencies and vaccine manufacturers to go through those steps as fast as possible.
Dave Daigle: Thank you. Next question, please, operator.
Operator: The next is from Donald McNeil, The New York Times. Your line is open.
Don McNeil: Hi. Thank you for taking a second one. I wanted to ask about infection control in schools. We’re seeing pictures now in New York City of the custodians wiping down door handles and washing the schools but if the schools are being closed for a week and the virus dies in 48 hours, that seems like a cosmetic exercise and I’m wondering — I don’t notice any infection guidelines, infection control guidelines for school on the CDC website or any other. I wonder if you have suggestions or plans for schools and what they would be and what do you do when the students come back into the school so you don’t get a resurgence?
Dan Jernigan: In terms of environmental infection control issues, there are different guidances that are not on the H1N1 influenza swine — excuse me — site. However, those guidances are on our infection control site and can be found there. But in particular here, the closing of the schools is in addition to allow for time so that transmission among those folks who are not in school can either burn out or get — have an opportunity to not be spread within the school environment. In terms of the specific guidance for infection control in schools, we do not have that on our website, but there are places on the CDC website that get out issues of environmental cleaning.
Dave Daigle: Thank you, Don. Next question, please, operator.
Operator: The next is from Helen Branswell, The Canadian Press. Your line is open.
Helen Branswell: Hi. Thanks for coming back to me as well. Dan, I’m clear about your answer to me and to John Cohen about the amount of activity that’s going on now. Do you think that there is more activity than would be normally seen at this time of year, or is it just more testing is being done? Is something weird going on? Is there an interplay of these viruses?
Dan Jernigan: I think the simple answer is yes, we think there is more activity. We are seeing it anecdotally, we are seeing it in our surveillance systems and we have a novel virus that has emerged for which there is no immunity in the fair amount of the population. So everything at this point suggests that there is ongoing activity and we’re seeing that in other countries as well, in this western hemisphere.
Dave Daigle: Thank you, Helen. I have just been handed a late breaker, so we will have Dr. Cetron make a short announcement.
Marty Cetron: I just wanted to indicate that later today, CDC would likely be posting a downgrade to the travel warning that is currently up regarding Mexico, which is at a level four alert that suggests folks defer not essential travel to Mexico. That will be downgraded to a travel precaution. And this will focus on providing particular precautionary advice to those individuals who are at high risk for complications of influenza. As Dr. Jernigan has probably already discussed in his brief, very high proportion of our hospitalizations are occurring among those who have underlying health conditions that put them at risk for complications, and our travel precaution will be particularly providing advice to those individuals regarding seeing their physician and getting specific advice on the feasibility and reasonableness for them. Bust the overall travel alert will be lowered from a warning to a precaution in that regard. And this information that we expect will be on the — on the CDC website later, by the end of the day today.
Dave Daigle: Dr. Martin Cetron, is the Director of the Global Migration and Quarantine Division. We do not plan a briefing right now pending any major developments for Saturday and Sunday. I want to thank everybody for joining us. Thanks very much. Good-bye.
End
####
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Quote:
http://www.cdc.gov/h1n1flu/update.htm#statetable
U.S. Human Cases of H1N1 Flu Infection
(As of May 15, 2009, 11:00 AM ET)
States* Confirmed and Probable Cases Deaths
Alabama
55
Arkansas
2
Arizona
435
1
California
504
Colorado
55
Connecticut
47
Delaware
60
Florida
68
Georgia
18
Hawaii
10
Idaho
5
Illinois
638
Indiana
71
Iowa
66
Kansas
30
Kentucky**
13
Louisiana
57
Maine
14
Maryland
28
Massachusetts
135
Michigan
142
Minnesota
36
Missouri
19
Montana
4
Nebraska
27
Nevada
26
New Hampshire
18
New Jersey
14
New Mexico
68
New York
242
North Carolina
12
North Dakota
2
Ohio
14
Oklahoma
26
Oregon
94
Pennsylvania
47
Rhode Island
8
South Carolina
36
South Dakota
4
Tennessee
74
Texas
506
2
Utah
91
Vermont
1
Virginia
21
Washington
246
1
Washington, D.C.
12
Wisconsin
613
TOTAL*(47)
4,714 cases
4 deaths
*includes the District of Columbia
**one case is resident of KY but currently hospitalized in GA.
This table will be updated daily Monday-Friday at around 11 AM ET.
International Human Cases of Swine Flu Infection
See: World Health Organization.
NOTE: Because of daily reporting deadlines, the state totals reported by CDC may not always be consistent with those reported by state health departments. If there is a discrepancy between these two counts, data from the state health departments should be used as the most accurate number.
#
http://www.who.int/csr/don/GlobalSubnationalMaster_20090515_0800.jpg
#
QUOTE:
http://www.who.int/csr/don/2009_05_15/en/index.html
Epidemic and Pandemic Alert and Response (EPR)
Country activities | Outbreak news | Resources | Media centre
WHO > Programmes and projects > Epidemic and Pandemic Alert and Response (EPR) > Disease Outbreak News
Main content
printable version
Influenza A(H1N1) - update 29
15 May 2009 — As of 06:00 GMT, 15 May 2009, 34 countries have officially reported 7520 cases of influenza A(H1N1) infection.
Mexico has reported 2446 laboratory confirmed human cases of infection, including 60 deaths. The United States has reported 4298 laboratory confirmed human cases, including three deaths. Canada has reported 449 laboratory confirmed human cases, including one death. Costa Rica has reported eight laboratory confirmed human cases, including one death.
Related links
Map of the spread of Influenza A(H1N1): number of laboratory confirmed cases and deaths [jpg 450kb]
As of 06:00 GMT, 15 May 2009
Influenza A(H1N1) web site
Daily updates will be posted on this site.
The following countries have reported laboratory confirmed cases with no deaths - Argentina (1), Australia (1), Austria (1), Belgium (1), Brazil (8), China (4), Colombia (10), Cuba (3), Denmark (1), El Salvador (4), Finland (2), France (14), Germany (12), Guatemala (3), Ireland (1), Israel (7), Italy (9), Japan (4), Netherlands (3), New Zealand (7), Norway (2), Panama (40), Poland (1), Portugal (1), Republic of Korea (3), Spain (100), Sweden (2), Switzerland (1), Thailand (2), and the United Kingdom (71).
WHO is not recommending travel restrictions related to the outbreak of the influenza A(H1N1) virus.
Individuals who are ill should delay travel plans and returning travelers who fall ill should seek appropriate medical care. These recommendations are prudent measures which can limit the spread of many communicable diseases, including influenza.
Further information on the situation will be available on the WHO web site on a regular basis.
#
http://www.who.int/csr/don/GlobalSubnationalMaster_20090516_1000.png
#
Note: The following text is a quote:
http://www.who.int/csr/don/2009_05_16/en/index.html
Epidemic and Pandemic Alert and Response (EPR)
Country activities | Outbreak news | Resources | Media centre
WHO > Programmes and projects > Epidemic and Pandemic Alert and Response (EPR) > Disease Outbreak News
Main content
printable version
Influenza A(H1N1) - update 30
16 May 2009 — As of 07:00 GMT, 16 May 2009, 36 countries have officially reported 8451 cases of influenza A(H1N1) infection.
Mexico has reported 2895 laboratory confirmed human cases of infection, including 66 deaths. The United States has reported 4714 laboratory confirmed human cases, including four deaths. Canada has reported 496 laboratory confirmed human cases, including one death. Costa Rica has reported nine laboratory confirmed human cases, including one death.
Related links
Map of the spread of Influenza A(H1N1): number of laboratory confirmed cases and deaths [png 221kb]
As of 07:00 GMT, 16 May 2009
Influenza A(H1N1) web site
Daily updates will be posted on this site.
The following countries have reported laboratory confirmed cases with no deaths - Argentina (1), Australia (1), Austria (1), Belgium (2), Brazil (8), China (4), Colombia (11), Cuba (3), Denmark (1), Ecuador (1), El Salvador (4), Finland (2), France (14), Germany (14), Guatemala (3), Ireland (1), Israel (7), Italy (9), Japan (4), Netherlands (3), New Zealand (9), Norway (2), Panama (43), Peru (1), Poland (1), Portugal (1), Republic of Korea (3), Spain (100), Sweden (2), Switzerland (1), Thailand (2), and the United Kingdom (78).
WHO is not recommending travel restrictions related to the outbreak of the influenza A(H1N1) virus.
Individuals who are ill should delay travel plans and returning travelers who fall ill should seek appropriate medical care. These recommendations are prudent measures which can limit the spread of many communicable diseases, including influenza.
Further information on the situation will be available on the WHO web site on a regular basis.
The CONSPIRACY and TOTAL NONSENSE Zone ON THE INTERNET:
http://www.memri.org/bin/articles.cgi?Page=countries&Area=iran&ID=SP235209
Special Dispatch - No. 2352
May 12, 2009 No. 2352
“Iranian TV: Swine Flu – A Zionist/American Conspiracy”
SNIPPET: “Following are excerpts from an Iranian TV report on swine flu, which aired on IRINN, the Iranian news channel, on May 6, 2009:
To view this clip, visit http://www.memritv.org/clip/en/2104.htm .”
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.
